The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity

Clinical Endocrinology

Volumn 72, Issue 3, 2010, Pages 334-341

  Mracek, T ^a   Ding, Q ^a   Tzanavari, T ^a   Kos, K ^a   Pinkney, J ^a   Wilding, J ^a   Trayhurn, P ^a   Bing, C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LEPTIN; MESSENGER RNA; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN; SEMINAL PLASMA PROTEIN; ZN ALPHA 2 GLYCOPROTEIN; ZN-ALPHA-2-GLYCOPROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; DOWN REGULATION; EMBRYO; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIMPSON GOLABI BEHMEL SYNDROME; SUBCUTANEOUS FAT; WESTERN BLOTTING; ABDOMINAL SUBCUTANEOUS FAT; METABOLISM; MIDDLE AGED; SECRETION;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ADIPOSITY; ADULT; FEMALE; GENE EXPRESSION; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; OBESITY; RNA, MESSENGER; SEMINAL PLASMA PROTEINS; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 76649083327     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03658.x     Document Type: Article

References (35)

1. Trayhurn, P. Bing, C. (2006) Appetite and energy balance signals from adipocytes. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 361, 1237 1249.
2. MacDougald, O.A. Burant, C.F. (2007) The rapidly expanding family of adipokines. Cell Metabolism, 6, 159 161.
3. Wang, P., Mariman, E., Renes, J. et al. (2008) The secretory function of adipocytes in the physiology of white adipose tissue. Journal of Cellular Physiology, 216, 3 13.
4. Trujillo, M.E. Scherer, P.E. (2005) Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine, 257, 167 175.
5. Kadowaki, T., Yamauchi, T., Kubota, N. et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation, 116, 1784 1792.
6. Guzik, T.J., Mangalat, D. Korbut, R. (2006) Adipocytokines - novel link between inflammation and vascular function? Journal of Physiology and Pharmacology, 57, 505 528.
7. Burgi, W. Schmid, K. (1961) Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. Journal of Biological Chemistry, 236, 1066 1074.
8. Tada, T., Ohkubo, I., Niwa, M. et al. (1991) Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. Journal of Histochemistry and Cytochemistry, 39, 1221 1226.
9. Sanchez, L.M., Chirino, A.J. Bjorkman, P. (1999) Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science, 283, 1914 1919.
10. Todorov, P.T., McDevitt, T.M., Meyer, D.J. et al. (1998) Purification and characterization of a tumor lipid-mobilizing factor. Cancer Research, 58, 2353 2358.
11. Hirai, K., Hussey, H.J., Barber, M.D. et al. (1998) Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Research, 58, 2359 2365.
12. Bing, C., Russell, S.T., Beckett, E.E. et al. (2002) Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. British Journal of Cancer, 86, 612 618.
13. Bing, C., Bao, Y., Jenkins, J. et al. (2004) Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proceedings of the National Academy of Sciences of the United States of America, 101, 2500 2505.
14. Bao, Y., Bing, C., Hunter, L. et al. (2005) Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Letters, 579, 41 47.
15. Bing, C., Russell, S., Becket, E. et al. (2006) Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. British Journal of Cancer, 95, 1028 1037.
16. Dahlman, I., Kaaman, M., Olsson, T. et al. (2005) A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. Journal of Clinical Endocrinology and Metabolism, 90, 5834 5840.
17. Tzanavari, T., Bing, C. Trayhurn, P. (2007) Postnatal expression of zinc-alpha2-glycoprotein in rat white and brown adipose tissue. Molecular and Cellular Endocrinology, 279, 26 33.
18. Gohda, T., Makita, Y., Shike, T. et al. (2003) Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity? Diabetes, 52, 2175 2181.
19. Wabitsch, M., Brenner, R.E., Melzner, I. et al. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. International Journal of Obesity and Related Metabolic Disorders, 25, 8 15.
20. Schagger, H. von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analytical Biochemistry, 166, 368 379.
21. Marrades, M.P., Martinez, J.A. Moreno-Aliaga, M.J. (2008) ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. Journal of Physiology Biochemistry, 64, 61 66.
22. Stejskal, D., Karpisek, M., Reutova, H. et al. (2007) Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clinical Biochemistry, 41, 313 316.
23. Hauner, H., Skurk, T. Wabitsch, M. (2001) Cultures of human adipose precursor cells. Methods in Molecular Biology, 155, 239 247.
24. Russell, S.T., Zimmerman, T.P., Domin, B.A. et al. (2004) Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochimica et Biophysica Acta, 1636, 59 68.
25. Rolli, V., Radosavljevic, M., Astier, V. et al. (2007) Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice. FEBS Letters, 581, 394 400.
26. Hu, G., Jousilahti, P., Tuomilehto, J. et al. (2009) Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. Journal of Clinical Endocrinology and Metabolism, 94, 2099 2105.
27. Russell, S.T. Tisdale, M.J. (2002) Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. British Journal of Cancer, 87, 580 584.
28. Yamauchi, T., Kamon, J., Waki, H. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7, 941 946.
29. Spranger, J., Kroke, A., Mohlig, M. et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet, 361, 226 228.
30. Bullo, M., Garcia-Lorda, P., Megias, I. et al. (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research, 11, 525 531.
31. Sartipy, P. Loskutoff, D.J. (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America, 100, 7265 7270.
32. Arita, Y., Kihara, S., Ouchi, N. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79 83.
33. Bruun, J.M., Lihn, A.S., Verdich, C. et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and Metabolism, 285, E527 E533.
34. Whitehead, J.P., Richards, A.A., Hickman, I.J. et al. (2006) Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obesity and Metabolism, 8, 264 280.
35. Kouyama, K., Miyake, K., Zenibayashi, M. et al. (2008) Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. Kobe Journal of Medical Sciences, 53, 345 354.